These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28527911)

  • 41. Clinical implication of targeting of cancer stem cells.
    Zhao L; Zhao Y; Bao Q; Niess H; Jauch KW; Bruns CJ
    Eur Surg Res; 2012; 49(1):8-15. PubMed ID: 22797579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of cancer stem cells (CD133(+)) in malignant gliomas.
    Cho DY; Lin SZ; Yang WK; Hsu DM; Lin HL; Lee HC; Lee WY; Chiu SC
    Cell Transplant; 2011; 20(1):121-5. PubMed ID: 20887676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent Advances in Cancer Stem Cell-Targeted Immunotherapy.
    Badrinath N; Yoo SY
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30841635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The clinical and therapeutic implications of cancer stem cell biology.
    Cheng L; Alexander R; Zhang S; Pan CX; MacLennan GT; Lopez-Beltran A; Montironi R
    Expert Rev Anticancer Ther; 2011 Jul; 11(7):1131-43. PubMed ID: 21806335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer.
    Zhao J; Li J; Schlößer HA; Popp F; Popp MC; Alakus H; Jauch KW; Bruns CJ; Zhao Y
    Stem Cells Int; 2017; 2017():6012810. PubMed ID: 28845161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer stem cells and tumor immunoediting: putting two and two together.
    Bhatia A; Kumar Y
    Expert Rev Clin Immunol; 2016 Jun; 12(6):605-7. PubMed ID: 26919116
    [No Abstract]   [Full Text] [Related]  

  • 47. Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies.
    Sainz B; Carron E; Vallespinós M; Machado HL
    Mediators Inflamm; 2016; 2016():9012369. PubMed ID: 26980947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer Precision Medicine: From Cancer Screening to Drug Selection and Personalized Immunotherapy.
    Deng X; Nakamura Y
    Trends Pharmacol Sci; 2017 Jan; 38(1):15-24. PubMed ID: 27842888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stem cell-derived exosomes: roles in stromal remodeling, tumor progression, and cancer immunotherapy.
    Fatima F; Nawaz M
    Chin J Cancer; 2015 Sep; 34(12):541-53. PubMed ID: 26369565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticancer innovative therapy: Highlights from the ninth annual meeting.
    Volpari T; De Santis F; Bracken AP; Pupa SM; Buschbeck M; Wegner A; Di Cosimo S; Lisanti MP; Dotti G; Massaia M; Pruneri G; Anichini A; Fortunato O; De Braud F; Del Vecchio M; Di Nicola M
    Cytokine Growth Factor Rev; 2020 Feb; 51():1-9. PubMed ID: 31862236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concise Review: An (Im)Penetrable Shield: How the Tumor Microenvironment Protects Cancer Stem Cells.
    Relation T; Dominici M; Horwitz EM
    Stem Cells; 2017 May; 35(5):1123-1130. PubMed ID: 28207184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dendritic cells loaded with pancreatic Cancer Stem Cells (CSCs) lysates induce antitumor immune killing effect in vitro.
    Yin T; Shi P; Gou S; Shen Q; Wang C
    PLoS One; 2014; 9(12):e114581. PubMed ID: 25521461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostate cancer stem cells and their potential roles in metastasis.
    Li H; Tang DG
    J Surg Oncol; 2011 May; 103(6):558-62. PubMed ID: 21480250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting cancer stem cells for treatment of glioblastoma multiforme.
    Cho DY; Lin SZ; Yang WK; Lee HC; Hsu DM; Lin HL; Chen CC; Liu CL; Lee WY; Ho LH
    Cell Transplant; 2013; 22(4):731-9. PubMed ID: 23594862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
    Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
    Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting neoantigens to augment antitumour immunity.
    Yarchoan M; Johnson BA; Lutz ER; Laheru DA; Jaffee EM
    Nat Rev Cancer; 2017 Apr; 17(4):209-222. PubMed ID: 28233802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. (R)Evolutionary therapy: the potential of immunotherapy to fulfill the promise of personalized cancer treatment.
    Madan RA; Gulley JL
    J Natl Cancer Inst; 2015 Jan; 107(1):347. PubMed ID: 25432410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Personalized approaches to active immunotherapy in cancer.
    Ophir E; Bobisse S; Coukos G; Harari A; Kandalaft LE
    Biochim Biophys Acta; 2016 Jan; 1865(1):72-82. PubMed ID: 26241169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel tools to assist neoepitope targeting in personalized cancer immunotherapy.
    Saini SK; Rekers N; Hadrup SR
    Ann Oncol; 2017 Dec; 28(suppl_12):xii3-xii10. PubMed ID: 29092006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic potential of cancer stem cells.
    Yang C; Jin K; Tong Y; Cho WC
    Med Oncol; 2015 Jun; 32(6):619. PubMed ID: 25920610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.